Real time insider trading transaction history:
- Insiders are prohibited from making short-swing profits by trading their shares within 6 months of the registration or acquiring the shares.
- Shares are not adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>
Common stock purchase or sale:
| Transaction Date |
Reported DateTime |
Company | Symbol | Insider Relationship |
Shares Traded |
Average Price |
Total Amount |
Shares Owned |
Filing |
| 2022-11-23 Purchase |
2022-11-23 4:05 pm |
Eledon Pharmaceuticals Inc. | ELDN | Perrin Steven President |
1,000 | $2.5969 | $2,597 | 1,000 (Direct) |
View |
Stock options: Exercise, Award, Grant, Conversion
| Transaction Date |
Reported DateTime |
Exercisable Expiration |
Company | Symnbol | Insider Relationship |
Shares Traded |
Conversion Price |
Shares Owned |
Filing |
| 2025-01-10 Option Award |
2025-01-13 5:30 pm |
N/A 2035-01-10 |
Eledon Pharmaceuticals Inc. | ELDN | Perrin Steven President |
270,000 | $0 | 270,000 (Direct) |
View |
| 2024-11-21 Option Award |
2024-11-22 5:00 pm |
N/A 2033-05-01 |
Eledon Pharmaceuticals Inc. | ELDN | Perrin Steven President |
840,438 | $0 | 840,438 (Direct) |
View |
| 2024-06-13 Option Award |
2024-06-14 5:00 pm |
N/A 2033-05-01 |
Eledon Pharmaceuticals Inc. | ELDN | Perrin Steven President |
428,148 | $0 | 428,148 (Direct) |
View |
| 2023-05-01 Option Award |
2023-05-02 6:50 pm |
N/A 2033-05-01 |
Eledon Pharmaceuticals Inc. | ELDN | Perrin Steven President |
317,147 | $0 | 317,147 (Direct) |
View |
| 2023-02-01 Option Award |
2023-02-02 6:11 pm |
N/A 2033-02-01 |
Eledon Pharmaceuticals Inc. | ELDN | Perrin Steven President |
155,000 | $0 | 155,000 (Direct) |
View |
| 2022-02-01 Option Award |
2022-02-02 5:37 pm |
N/A 2032-02-01 |
Eledon Pharmaceuticals Inc. | ELDN | Perrin Steven President |
155,000 | $0 | 155,000 (Direct) |
View |
Ownership |
2020-09-24 7:44 pm |
N/A 2030-09-14 |
Novus Therapeutics Inc. | NVUS | Perrin Steven See Remarks |
0 | $0 | 395,146 (Direct) |
View |